Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

The world's most comprehensive cannabis strain directory, backed by scientific research.

Explore

Strain Directory Indica Strains Sativa Strains Hybrid Strains Breeders

Research

Research Database Medical Conditions Pain Relief Anxiety Insomnia

Tools

Strain Comparator Strain Explorer Blog API

© 2026 BudProfiles. For informational and educational purposes only.

Privacy Policy Terms of Service Disclaimer

11,121 strains · 12,304 studies · 268 breeders

Best Cannabis Strains for Fibrosis - Liver (Cirrhosis) — 0 Strains, 0 Studies | BudProfiles

Home

Conditions

Fibrosis - Liver (Cirrhosis)

Cannabis & Fibrosis - Liver (Cirrhosis)

Explore 0 strains and 0 scientific studies related to Fibrosis - Liver (Cirrhosis).

0

Strains

0

Studies

18

Positive Studies

93%

Evidence Score

Research Evidence

18

Positive (90.0%)

0

Negative (0.0%)

2

Inconclusive (10.0%)

Scientific Studies

Hepatoprotective Effect Assessment of C-Phycocyanin on Hepatocellular Carcinoma Rat Model by Using Photoacoustic Spectroscopy

2024·Animal Study -

Formulation and Characterization of O/W Nanoemulsions of Hemp Seed Oil for Protection from Steatohepatitis: Analysis of Hepatic Free Fatty Acids and Oxidation Markers

2022·Review/Other

Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model

2022·Animal Study -

Observed Impact of Long-term Consumption of Oral Cannabidiol on Liver Function in Healthy Adults

2021·Review/Other

Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice

2021·Animal Study -

Pharmacologic Antagonization of Cannabinoid Receptor 1 Improves Cholestasis in Abcb4-/- Mice

2021·Animal Study -

Therapeutic potential of beta-caryophyllene against aflatoxin B1-Induced liver toxicity: biochemical and molecular insights in rats

2021·Animal Study -

The peripheral CB 1 receptor antagonist JD5037 attenuates liver fibrosis via a CB 1 receptor/β-arrestin1/Akt pathway

2020·Review/Other

Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review

2020·Animal Study - Veterinary Clinical Trial

Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort)

2020·Review/Other

Cannabis Use May Reduce Healthcare Utilization and Improve Hospital Outcomes in Patients with Cirrhosis

2020·Review/Other

Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential?

2020·Review/Other

Cannabinoids and Chronic Liver Diseases

2020·Review/Other

Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications

2019·Animal Study - Veterinary Clinical Trial

Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis

2019·Review/Other

Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients

2019·Review/Other

Opposite roles of cannabinoid receptor 1 and 2 in hepatocarcinogenesis

2019·Review/Other

Effect of a Multistrain Probiotic on Cognitive Function and Risk of Falls in Patients With Cirrhosis: A Randomized Trial

2019·Clinical Trial

The effects of oleoylethanolamide, an endogenous PPAR-α agonist, on risk factors for NAFLD: A systematic review

2019·Meta-analysis -

Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis.

2018·Review/Other